硬膜外导管设计对程序性间歇硬膜外注射镇痛效果的影响:一项随机双盲对照试验。

IF 5.1 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2025-09-02 eCollection Date: 2025-01-01 DOI:10.2147/DDDT.S545076
Yibing Yu, Qingsong Zhao, Yu Zang, Zhiqiang Liu, Weijia Du
{"title":"硬膜外导管设计对程序性间歇硬膜外注射镇痛效果的影响:一项随机双盲对照试验。","authors":"Yibing Yu, Qingsong Zhao, Yu Zang, Zhiqiang Liu, Weijia Du","doi":"10.2147/DDDT.S545076","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare analgesic outcomes between single- and multi-orifice epidural catheters at a 360-mL/h delivery rate during programmed intermittent epidural bolus.</p><p><strong>Patients and methods: </strong>In this prospective randomized double-blinded controlled trial, 102 healthy nulliparous parturients requesting labor analgesia at the Shanghai First Maternity and Infant Hospital were enrolled from July to September 2023. Participants were given either single- or multi-orifice catheters for epidural analgesia (0.1% ropivacaine with 0.3 µg/mL of sufentanil; 10 mL every 45 min at 360 mL/h). The primary outcome was ropivacaine consumption per hour, calculated as the total amount of ropivacaine administered divided by the duration of labor analgesia (mg/h).</p><p><strong>Results: </strong>Median ropivacaine consumption per hour was not significantly different: 12.6 mg/h [11.6-13.2 mg/h] for single-orifice vs 12.8 mg/h [12.3-13.3 mg/h] for multi-orifice catheters (difference 29%; 95% confidence interval [CI], -10.2 to 68.2%; <i>P</i>=0.241). No significant differences were found in patient-controlled epidural analgesia boluses requested and delivered, time to first bolus request, or the number of clinician-administered boluses. However, adequate analgesia at 20 min was higher with single-orifice catheters (84.0% vs 63.5%, difference 22.5%; 95% CI: 9.2% to 35.1%, <i>P</i>=0.019). Median times to adequate analgesia were 8 min [4-16] vs 15 min [9.5-22.5] for single- and multi-orifice catheters (<i>P</i>=0.002). Pain scores differed only at 6 and 18 min. There were no differences in the incidence of motor or unilateral block, side effects, maternal satisfaction, or catheter-related complications between the two groups.</p><p><strong>Conclusion: </strong>Single-orifice catheters did not enhance analgesia quality during labor maintenance under a 360-mL/h programmed intermittent epidural bolus delivery rate but were linked to more rapid analgesic onset than multi-orifice catheters.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"7581-7590"},"PeriodicalIF":5.1000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413817/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effect of Epidural Catheter Design on Analgesic Efficacy During Programmed Intermittent Epidural Boluses: A Randomized Double-Blinded Controlled Trial.\",\"authors\":\"Yibing Yu, Qingsong Zhao, Yu Zang, Zhiqiang Liu, Weijia Du\",\"doi\":\"10.2147/DDDT.S545076\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To compare analgesic outcomes between single- and multi-orifice epidural catheters at a 360-mL/h delivery rate during programmed intermittent epidural bolus.</p><p><strong>Patients and methods: </strong>In this prospective randomized double-blinded controlled trial, 102 healthy nulliparous parturients requesting labor analgesia at the Shanghai First Maternity and Infant Hospital were enrolled from July to September 2023. Participants were given either single- or multi-orifice catheters for epidural analgesia (0.1% ropivacaine with 0.3 µg/mL of sufentanil; 10 mL every 45 min at 360 mL/h). The primary outcome was ropivacaine consumption per hour, calculated as the total amount of ropivacaine administered divided by the duration of labor analgesia (mg/h).</p><p><strong>Results: </strong>Median ropivacaine consumption per hour was not significantly different: 12.6 mg/h [11.6-13.2 mg/h] for single-orifice vs 12.8 mg/h [12.3-13.3 mg/h] for multi-orifice catheters (difference 29%; 95% confidence interval [CI], -10.2 to 68.2%; <i>P</i>=0.241). No significant differences were found in patient-controlled epidural analgesia boluses requested and delivered, time to first bolus request, or the number of clinician-administered boluses. However, adequate analgesia at 20 min was higher with single-orifice catheters (84.0% vs 63.5%, difference 22.5%; 95% CI: 9.2% to 35.1%, <i>P</i>=0.019). Median times to adequate analgesia were 8 min [4-16] vs 15 min [9.5-22.5] for single- and multi-orifice catheters (<i>P</i>=0.002). Pain scores differed only at 6 and 18 min. There were no differences in the incidence of motor or unilateral block, side effects, maternal satisfaction, or catheter-related complications between the two groups.</p><p><strong>Conclusion: </strong>Single-orifice catheters did not enhance analgesia quality during labor maintenance under a 360-mL/h programmed intermittent epidural bolus delivery rate but were linked to more rapid analgesic onset than multi-orifice catheters.</p>\",\"PeriodicalId\":11290,\"journal\":{\"name\":\"Drug Design, Development and Therapy\",\"volume\":\"19 \",\"pages\":\"7581-7590\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12413817/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Design, Development and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/DDDT.S545076\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S545076","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:比较单孔硬膜外导管和多孔硬膜外导管在计划间歇硬膜外灌注时360-mL/h的镇痛效果。患者和方法:在这项前瞻性随机双盲对照试验中,于2023年7月至9月在上海第一妇幼医院接受分娩镇痛的102例健康未产产妇入组。参与者被给予单孔或多孔导管用于硬膜外镇痛(0.1%罗哌卡因加0.3 μ g/mL舒芬太尼;每45分钟10ml,速度为360 mL/h)。主要终点为每小时罗哌卡因用量,计算方法为罗哌卡因总用量除以分娩镇痛持续时间(mg/h)。结果:每小时罗哌卡因用量中位数无显著差异:单孔导管12.6 mg/h [11.6-13.2 mg/h] vs多孔导管12.8 mg/h [12.3-13.3 mg/h](差异29%;95%可信区间[CI], -10.2 ~ 68.2%; P=0.241)。在患者控制的硬膜外镇痛丸的请求和交付、第一次请求的时间或临床给药的数量方面没有发现显着差异。然而,单孔导管在20分钟的充分镇痛率更高(84.0% vs 63.5%,差异22.5%;95% CI: 9.2% ~ 35.1%, P=0.019)。单孔和多孔导管达到充分镇痛的中位时间为8分钟[4-16],而15分钟[9.5-22.5](P=0.002)。疼痛评分仅在6分钟和18分钟时不同。两组在运动或单侧阻滞、副作用、产妇满意度或导管相关并发症的发生率方面没有差异。结论:在360 ml /h的间歇硬膜外输注率下,单孔导管并不能提高分娩维持过程中的镇痛质量,但与多孔导管相比,单孔导管的镇痛起效更快。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Effect of Epidural Catheter Design on Analgesic Efficacy During Programmed Intermittent Epidural Boluses: A Randomized Double-Blinded Controlled Trial.

Effect of Epidural Catheter Design on Analgesic Efficacy During Programmed Intermittent Epidural Boluses: A Randomized Double-Blinded Controlled Trial.

Effect of Epidural Catheter Design on Analgesic Efficacy During Programmed Intermittent Epidural Boluses: A Randomized Double-Blinded Controlled Trial.

Purpose: To compare analgesic outcomes between single- and multi-orifice epidural catheters at a 360-mL/h delivery rate during programmed intermittent epidural bolus.

Patients and methods: In this prospective randomized double-blinded controlled trial, 102 healthy nulliparous parturients requesting labor analgesia at the Shanghai First Maternity and Infant Hospital were enrolled from July to September 2023. Participants were given either single- or multi-orifice catheters for epidural analgesia (0.1% ropivacaine with 0.3 µg/mL of sufentanil; 10 mL every 45 min at 360 mL/h). The primary outcome was ropivacaine consumption per hour, calculated as the total amount of ropivacaine administered divided by the duration of labor analgesia (mg/h).

Results: Median ropivacaine consumption per hour was not significantly different: 12.6 mg/h [11.6-13.2 mg/h] for single-orifice vs 12.8 mg/h [12.3-13.3 mg/h] for multi-orifice catheters (difference 29%; 95% confidence interval [CI], -10.2 to 68.2%; P=0.241). No significant differences were found in patient-controlled epidural analgesia boluses requested and delivered, time to first bolus request, or the number of clinician-administered boluses. However, adequate analgesia at 20 min was higher with single-orifice catheters (84.0% vs 63.5%, difference 22.5%; 95% CI: 9.2% to 35.1%, P=0.019). Median times to adequate analgesia were 8 min [4-16] vs 15 min [9.5-22.5] for single- and multi-orifice catheters (P=0.002). Pain scores differed only at 6 and 18 min. There were no differences in the incidence of motor or unilateral block, side effects, maternal satisfaction, or catheter-related complications between the two groups.

Conclusion: Single-orifice catheters did not enhance analgesia quality during labor maintenance under a 360-mL/h programmed intermittent epidural bolus delivery rate but were linked to more rapid analgesic onset than multi-orifice catheters.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信